Mean telomere length measured in human lymphoma and myeloma cell lines
Cell line (tumor) . | Characteristics . | Mean TRF, kb . |
|---|---|---|
| CAG (myeloma) | CD38+EBV-CD19- IgG κ chain | 2.7 |
| SK0-007 subclone (myeloma) | IgE λ light chain EBV+ | 1.7 |
| U266 (myeloma) | CD38+ IgE λ light chain | 9.0 |
| Hs602 (lymphoma) | CD19+CD20+CD45+CD25-CD3- | 2.7 |
| HT (lymphoma) | CD19+CD20+CD21+CD22+CD25- p53 mutant | 11.0 |
| RL (lymphoma) | CD19+CD20+CD21+CD22+bcl-2+ t(14;18), p53 mutant | 5.4 |
| SKI-DLBCL1 (lymphoma) | CD19+CD20+CD45+CD3-CD5-CD10- CD23-EBV- | 4.9 |
Cell line (tumor) . | Characteristics . | Mean TRF, kb . |
|---|---|---|
| CAG (myeloma) | CD38+EBV-CD19- IgG κ chain | 2.7 |
| SK0-007 subclone (myeloma) | IgE λ light chain EBV+ | 1.7 |
| U266 (myeloma) | CD38+ IgE λ light chain | 9.0 |
| Hs602 (lymphoma) | CD19+CD20+CD45+CD25-CD3- | 2.7 |
| HT (lymphoma) | CD19+CD20+CD21+CD22+CD25- p53 mutant | 11.0 |
| RL (lymphoma) | CD19+CD20+CD21+CD22+bcl-2+ t(14;18), p53 mutant | 5.4 |
| SKI-DLBCL1 (lymphoma) | CD19+CD20+CD45+CD3-CD5-CD10- CD23-EBV- | 4.9 |
TRF measurement performed as described in “Patients, materials, and methods.” Ig indicates immunoglobulin.